LINK: https://us06web.zoom.us/j/85099759729?pwd=Y3GSQZXQX1H0wgxXL7YZZu2mP8pozW.1&from=addon

OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) define progressive pulmonary fibrosis, restrictive ventilatory dysfunction, and hypoxemia with regards to Interstitial lung disease (ILD), (2) explain the clinical benefits of pulmonary rehabilitation with different characteristics in ILD patients, (3) analyze the benefits of combinational effects of endurance, resistance training combined with respiratory training within the ILD population compared to other protocols (Chen et al., 2025); (4) identify optimal pulmonary rehabilitation program components, (5) discuss the best timing of pulmonary rehabilitation initiation, (6) discuss the differences in initiating pulmonary rehabilitation in patients with stable COPD vs acute exacerbation (Chen et al., 2025).

FACULTY DISCLOSURE: Ashkan Khosravi, D.O. (PGY-4) and Mason Tincher, D.O. (PGY-3) have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Recording of this educational activity, including the use of AI tools, is prohibited.

For information, please contact Alina Manjiyani at [email protected]